Ann Coloproctol 2015;31(2):74-78 http://dx.doi.org/10. 3393/ac.2015.31.2.74 We report a case of a goblet-cell carcinoid tumor of the appendix which metastasized to the peritoneum and was treated by using cytoreductive surgery (CRS) with intraperitoneal chemotherapy. A 47-year-old male presented with chronic constipation and was diagnosed as having a rectal adenocarcinoma with a signet-ring-cell component under colonoscopy. Computed tomography suggested peritoneal metastases with diffuse nodular parietal peritoneal thickening of the entire abdomen and focal invasion of the upper rectum by a seeding mass. CRS with intraperitoneal chemotherapy was done under the diagnosis of a rectal adenocarcinoma with peritoneal metastases. The pathologic diagnosis was a goblet-cell carcinoid tumor of the appendix with peritoneal metastasis. The histological discrepancy between a peritoneal metastatic mass and a rectal mass was due to the mixed histological pattern of a goblet-cell carcinoid tumor. A metastatic mass may not share identical immunohistochemical characteristics from its origin. This histologic discrepancy necessitates caution in diagnosing a distant metastasis of a goblet-cell carcinoid tumor.
INTRODUCTION
Goblet-cell carcinoid (GCC) tumors are rare tumors arising almost exclusively in the appendix [1] and having a mixed neuroendocrine and goblet-cell-type morphology [2] . A GCC was first recognized as a separate entity in 1969 by Gagne et al. [3] . We report a GCC of the appendix which manifested as metastasis to the peritoneum. This case shows diverse histological findings between the primary site lesion and the metastatic lesion.
CASE REPORT
A 47-year-old male visited a local hospital presenting with no other symptoms except for several months of chronic constipation. A colonoscopic exam revealed a mass-like lesion in the rectum, and pathology confirmed the lesion to be an adenocarcinoma with a signet-ring-cell carcinoma component (Fig. 1 ). Full examination of the entire colon failed due to the patient' s complaining of severe pain as the scope passed through the cecal area. A subsequent computed tomography scan showed a peritoneal carcinomatosisascites along the upper abdomen, diffuse nodular parietal peritoneal thickening along the perihepatic space extending into the perisplenic area and the right lateral abdomen, a diffuse peritoneal seeding nodular mass lesion along the mesentery of the right mid to lower abdomen, central the mid to lower abdomen, a rectovesical space, suggestive of focal invasion of urinary bladder' s posterior and superior wall side, and focal invasion of the upper rectum by the seeding mass lesion (Fig. 2) .
The initial impression was rectal cancer with peritoneal seeding. Upon surgical examination, extensive metastatic seeding nodules were seen throughout the abdominal cavity, including the entire peritoneum, as well as the colon, small bowel mesentery, surface of the stomach, spleen, diaphragm, and surface of the liver (Fig.  3A) . The most severe metastatic region was the pelvic cavity. The rectum, distal ileum, and metastatic masses were conglomerated to form a hard mass. The rectal mass, which was initially thought to be a primary mass, proved to be a metastatic mass penetrating the rectum. A peritonectomy, omentectomy, total colectomy, splenectomy, small bowel resection, and end ileostomy were performed (Fig. 3B) , and early postoperative intraperitoneal chemo- The pathologic diagnosis was a GCC (8 cm × 8 cm × 7 cm) arising from the appendix. The mass had penetrated the visceral peritoneum with tumor metastases to 4 of 9 regional lymph nodes. The immunohistochemical result of the GCC showed positive for chromogranin A, synaptophysin, carcinoembryonic antigen, and CK20. The Ki-67 was moderate to high in proliferative activity. Meanwhile, the rectal mass showed features of a poorly differentiated adenocarcinoma with a signet-ring-cell component. No components of chromogranin A, synaptophysin, or CD56 were found in the metastatic mass (Fig. 4) . A 5-day regimen of intraperitoneal chemotherapy was administered, after which the patient was discharged. Subsequent to his discharge, the patient underwent 5-FU+Oxaliplatin (FOLFOX4) chemotherapy. The patient remains well without any recurrence or any complications at 6 months after the surgery.
DISCUSSION
GCC tumors are unusual tumors of the appendix and were first described by Subbuswamy et al. [4] in 1974. While an appendiceal adenocarcinoma mimics the characteristics of a colonic adenocarcinoma and an appendiceal carcinoid tumor shows a neuroendocrine phenotype, an appendiceal GCC shows a mixed phenotype of neuroendocrine differentiation and intestinal-type goblet-cell morphology [5] . So far, they are thought to originate from pluripotent intestinal crypt-base stem cells [6, 7] . Immunohistologically, GCCs are positive for chromogranin A and synaptophysin. They are crucial biomarkers for classic neuroendocrine tumors, showing diffuse positivity in carcinoid tumors. In a GCC, however, only the focal parts of the neoplasm are stained positive. This may mean that the biopsy from the metastatic mass may lack cell components that stain positive for chromogranin A or synaptophysin. As a result, the immunoprofile of the metastatic tumor can vary from that of its primary tumor. Our case shows that this discrepancy in the immunohistochemical results may be a confounding factor in confirming the diagnosis of the primary tumor.
Because a GCC tumor does not present with any specific symptoms other than an acute abdomen, diagnosis is almost always made postoperatively and often in a late stage of the disease. One review study showed that 11.16% of the patients presented with a distant metastasis at the time of diagnosis, ovaries being the most common with an incidence of 3.60%, followed by abdominal carcinomatosis with an incidence of 1.03% [7] . In our case, the peritoneal seeding disseminated diffusely into the entire abdomen. The seeding nodule in the rectum had infiltrated the bowel wall from the serosal side, causing the metastatic mass to be mistaken for a rectal mass. Despite its low prevalence, a GCC should be a consideration when multiple tumors are found in the appendix and colon. Also, a full examination of the gastrointestinal tract needs to be done before deciding on the primary focus of the tumor.
The treatment for a GCC is surgical removal of the tumor, and a GCC can usually be successfully treated with a simple appendectomy. Controversies exist about whether a right hemicolectomy should be performed or a simple appendectomy would suffice. In a review of surgeries performed on patients with a GCC, a simple appendectomy was performed in 24.57% of the cases and right hemicolectomy in 34.7% of the cases [7] . The treatment modality for a GCC with peritoneal seeding is also controversial, but recent reports advocate cytoreductive surgery (CRS) followed by intraperitoneal chemotherapy [8] [9] [10] [11] . Our patient initially showed a peritoneal cancer index (PCI) of 30, and he showed completeness of cytoreduction of CC2. In appendiceal tumors, the PCI is not important as a prognostic factor [12] . Because appendiceal tumors show good response to chemotherapy and the patient was fairly young and apparently healthy, we proceeded with the surgery. Evidently, complete cytoreduction is required for optimal results, but in our case, the tumor dissemination was too advanced.
Although a complete resection of the tumor cells was not possible in our case, aggressive debulking surgery combined with intraperitoneal and systemic chemotherapy proved to be a successful option for the treatment of the advanced appendiceal GCC with peritoneal seeding. However, further clinical follow up and an accumulation of cases are needed to obtain more knowledge concerning the prognosis for patients presenting with a GCC with peritoneal seeding. 
